Weisel K

Publishing 2012–2014

Is this you? Claim this profile
2
Articles
1,022
Reads on Journament
54
Co-authors
1
Journal

This page collects the articles indexed under the name Weisel K. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 2

  1. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
  2. Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Possible papers by Weisel K 4

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
    as Katja C Weisel The New England journal of medicine 2019 Emory University
    Same journal
  2. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
    as Katja Christina Weisel Lancet (London, England) 2019
    Same name only
  3. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
    as Katja Weisel the lancet oncology 2016 Universitätsklinikum Tübingen
    Same name only
  4. Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
    as Katja Weisel Clinical Lymphoma Myeloma and Leukemia 2015
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in